Kiora Pharmaceuticals, Inc. (KPRX)

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.58	2.45	5.96	7.85	1.19	3.78
Cash & Short-Term Investments	27.82	2.45	5.96	7.85	1.19	3.78
Cash Growth	249.84%	-58.85%	-24.06%	562.46%	-68.61%	-52.82%
Other Receivables	2.33	2.05	1.37	0.53	0.09	0
Receivables	3.67	2.05	1.37	0.53	0.09	0
Prepaid Expenses	0.2	0.23	0.34	0.61	0.45	0.46
Other Current Assets	0.14	-	-	-	-	0.08
Total Current Assets	31.83	4.74	7.68	8.99	1.73	4.32
Property, Plant & Equipment	0.15	0.11	0.17	0.28	0.11	0.02
Goodwill	-	-	-	-	3.63	1.53
Other Intangible Assets	8.8	0.12	0.14	0.17	0.19	0.22
Long-Term Deferred Charges	-	8.7	10.6	10.6	9.54	3.91
Other Long-Term Assets	0.04	0.05	0.08	0.09	0.1	0.11
Total Assets	40.81	13.71	18.68	20.13	15.3	10.11
Accounts Payable	0.27	0.21	1.01	0.16	0.43	0.21
Accrued Expenses	1.25	1.38	1.84	1.33	1.29	1.12
Current Portion of Long-Term Debt	-	-	-	-	0.21	-
Current Portion of Leases	0.04	0.05	0.11	0.12	0.05	0.08
Other Current Liabilities	-	-	0.32	-	-	-
Total Current Liabilities	1.66	1.63	3.27	1.61	1.98	1.41
Long-Term Debt	-	-	-	-	0.28	-
Long-Term Leases	0.04	0.06	-	0.09	0.04	-
Long-Term Deferred Tax Liabilities	0.78	0.78	0.69	0.8	0.73	0.37
Other Long-Term Liabilities	5.24	5.13	3.31	3.05	2.55	1.71
Total Liabilities	7.71	7.6	7.27	5.55	5.57	3.49
Common Stock	0.27	0.08	0.02	0	0.06	0.04
Additional Paid-In Capital	168.83	153.19	146.04	135.54	116.78	106.69
Retained Earnings	-135.75	-146.98	-134.46	-120.88	-107.11	-100.25
Comprehensive Income & Other	-0.25	-0.18	-0.18	-0.09	-0	0.14
Total Common Equity	33.1	6.11	11.41	14.58	9.73	6.62
Shareholders' Equity	33.1	6.11	11.41	14.58	9.73	6.62
Total Liabilities & Equity	40.81	13.71	18.68	20.13	15.3	10.11
Total Debt	0.08	0.11	0.11	0.21	0.57	0.08
Net Cash (Debt)	27.74	2.35	5.86	7.65	0.61	3.69
Net Cash Growth	250.52%	-59.93%	-23.37%	1150.70%	-83.45%	-53.84%
Net Cash Per Share	11.51	4.36	72.00	285.39	47.93	-
Filing Date Shares Outstanding	2.97	2.92	0.21	0.04	0.02	0.01
Total Common Shares Outstanding	2.97	0.86	0.2	0.04	0.02	0.01
Working Capital	30.17	3.1	4.41	7.38	-0.26	2.91
Book Value Per Share	11.14	7.14	57.15	414.44	630.41	584.66
Tangible Book Value	24.3	5.99	11.26	14.41	5.9	4.88
Tangible Book Value Per Share	8.18	7.00	56.43	409.64	382.58	430.63
Machinery	-	0.01	0.15	0.16	0.1	0.08
Leasehold Improvements	-	-	0.02	0.02	0.02	0.02

Source: S&P Capital IQ. Standard template. Financial Sources.